It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the saturated venous oxygen (svo2) reading was 10-15 points lower than expected with the blood parameter monitor (bpm).The device was not changed out, as they recalibrated the unit.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the pt.Per the clinical review on 04/23/2015: the perfusionist (ccp) admitted that since the 1.69 software upgrade of this monitor, the svo2 measure is less than previously seen with the previous software version (1.65) and lower than their laboratory analyzer (especially prior to the 1st in-vivo calibration).Prior to the first in-vivo calibration (in the first 15-20 minutes of cpb), the svo2 measure of the bpm is consistently 10-15% points less than their independent laboratory analyzer.This means that in the early minutes of cpb, the bpm svo2 level is generally in the 55-60% range, while the laboratory analyzed svo2 is in the 65-75% range.According to the ccp, the bpm lower svo2 values were doubted in the early minutes of cpb as the color of the blood was brighter (red) than what the bpm svo2 values indicated.The ccp stated that prior to the 1.69 upgrade, the svo2 measures of the bpm and the laboratory analyzer were close in measurement.The ccp stated that after the in-vivo calibration, the svo2 would more closely match in some cases but in others the difference would remain 5-10% (with the bpm also being lower than the laboratory analyzed value).According to the ccp, accuracy of the other parameters measured with the hematocrit saturation module (h/sat) probe (hemoglobin [hgb] and hematocrit [hct] and the arterial shunt measurements (with bpm) have not been an issue with the 1.69 upgrade.Due to this issue, additional venous samples (more than with 1.65 software) are drawn.Since the other measured values of the bpm have been reasonable, the bpm has not been changed out during the procedures.Cases have been completed successfully, without delay and without associated blood loss.There has been no harm observed.
|
The reported complaint was not confirmed.The blood parameter monitor (bpm) was returned to the manufacturer for evaluation and was found to meet specifications.In the product surveillance lab, no errors or failures were observed.Blood loop testing was performed for oxygen saturation (so2) inaccuracies on both the 1/2" and 1/4" cuvette sizes.The monitor met specifications with no inaccuracies observed during blood loop testing.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
|